APA (7th ed.) Citation

Phuan, P., Tan, J., Rivera, A. A., Zlock, L., Nielson, D. W., Finkbeiner, W. E., . . . Verkman, A. S. (2019). Nanomolar-potency ‘co-potentiator’ therapy for cystic fibrosis caused by a defined subset of minimal function CFTR mutants. Scientific reports, 9(1), 17640-12. https://doi.org/10.1038/s41598-019-54158-2

Chicago Style (17th ed.) Citation

Phuan, Puay-Wah, Joseph-Anthony Tan, Amber A. Rivera, Lorna Zlock, Dennis W. Nielson, Walter E. Finkbeiner, Peter M. Haggie, and Alan S. Verkman. "Nanomolar-potency ‘co-potentiator’ Therapy for Cystic Fibrosis Caused by a Defined Subset of Minimal Function CFTR Mutants." Scientific Reports 9, no. 1 (2019): 17640-12. https://doi.org/10.1038/s41598-019-54158-2.

MLA (9th ed.) Citation

Phuan, Puay-Wah, et al. "Nanomolar-potency ‘co-potentiator’ Therapy for Cystic Fibrosis Caused by a Defined Subset of Minimal Function CFTR Mutants." Scientific Reports, vol. 9, no. 1, 2019, pp. 17640-12, https://doi.org/10.1038/s41598-019-54158-2.